New heart pump could save lives after surgery shock
NCT ID NCT07560085
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called SynFlow Duro, a temporary heart pump for people who go into severe shock after heart surgery. About 60 adults in China will receive the pump to see if it helps their heart recover or keeps them stable until a transplant or permanent device. The goal is to improve survival and reduce the need for other emergency support.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a temporary heart pump save more lives in cardiogenic shock?
- Could starting dialysis sooner save more hearts?
- A tiny probe into the heart's hidden reserve could forecast who needs a transplant
- Can a tiny heart pump Fine-Tune support for failing hearts?
- Could a key hormone be missing in septic shock?
- Could a simple filter tame the deadly inflammation of heart shock?